A hypoxia-activated nano prodrug for enhanced chemotherapy and photodynamic synergistic therapy with minimized chemotherapy side effect
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · Advanced Nanomaterials in Catalysis · Luminescence and Fluorescent Materials
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (52)
Show source-provided references
1. In vivo-assembled phthalocyanine/albumin supramolecular complexes combined with a hypoxia-activated prodrug for enhanced photodynamic immunotherapy of cancer10.1016/j.biomaterials.2020.120430 ↗
2. Light-triggered nanozymes remodel the tumor hypoxic and immunosuppressive microenvironment for ferroptosis-enhanced antitumor immunity10.1021/acsnano.4c00844 ↗
3. A “precision medicine” nanoplatform for synergistic photothermal therapy and chemotherapy in hepatocellular carcinoma
4. Engineering supramolecular nanomedicine for targeted near infrared-triggered mitochondrial dysfunction to potentiate cisplatin for efficient chemophototherapy10.1021/acsnano.1c09555 ↗
5. A CuS/Ag/Pt@ICG/DOX nanoplatform with cascaded nanozyme catalysis for tumor microenvironment remodeling and synergistic photodynamic/photothermal/chemodynamic therapy10.1016/j.colsurfb.2025.114743 ↗
6. pH-responsive AIE nanogels for synergistic chemo-photodynamic cancer therapy with imaging guidance10.1007/s11426-024-2379-x ↗
7. Nuclear-targeted smart nanoplatforms featuring double-shell hollow mesoporous copper sulfide coated with manganese dioxide synergistically potentiate chemotherapy and immunotherapy in hepatocellular carcinoma cells10.1016/j.jcis.2024.11.003 ↗
8. “transforming enemy into friend” strategy-based stimuli responsive dual-drug liposomes for synergistic chemo-photodynamic therapy10.1016/j.cej.2024.150526 ↗
9. A nanomedicine composed of polymer-ss-DOX and polymer-Ce6 prodrugs with monoclonal antibody targeting effect for anti-tumor chemo-photodynamic synergetic therapy10.1016/j.actbio.2024.02.048 ↗
10. Tumor-activated photosensitization and size transformation of nanodrugs
11. Enzyme-responsive double-locked photodynamic molecular beacon for targeted photodynamic anticancer therapy10.1021/jacs.2c13732 ↗
12. A glutathione activatable pro-drug-photosensitizer for combined chemotherapy and photodynamic therapy10.1016/j.cclet.2022.03.040 ↗
13. Hypoxia exacerbation-triggered doxorubicin prodrug activation for sequential photodynamic/chemotherapy10.1021/acsmaterialslett.4c00798 ↗
14. Hypoxia-activated PEGylated paclitaxel prodrug nanoparticles for potentiated chemotherapy10.1021/acsnano.2c05341 ↗
15. Mechanisms of vasculogenic mimicry in hypoxic tumor microenvironments10.1186/s12943-020-01288-1 ↗
16. A hypoxia-activated and microenvironment-remodeling nanoplatform for multifunctional imaging and potentiated immunotherapy of cancer10.1038/s41467-024-53906-x ↗
17. Hypoxia-adaptive penetration enhanced nanomedicine regulating cell–internalization ability enabling the uniform distribution within tumors
18. Engineered hypoxia-responsive albumin nanoparticles mediating mitophagy regulation for cancer therapy10.1038/s41467-025-55905-y ↗
19. Photodynamic therapy-accelerated hypoxia-responsive prodrug release for synergistic photo-chemotherapy of melanoma cancer based on noncovalent interactions10.1021/acsmaterialslett.4c02496 ↗
20. A photo-accelerated nanoplatform for image-guided synergistic chemo-photodynamic therapy
21. Enhancing the release efficiency of a molecular chemotherapeutic prodrug by photodynamic therapy10.1002/anie.202206169 ↗
22. A hypoxia-activated BODIPY-azo anticancer prodrug for bimodal chemo-photodynamic therapy10.1021/acs.jmedchem.4c02231 ↗
23. A dendritic drug–drug conjugate self-assembled hypoxia-responsive supramolecular nanoparticle for combination therapy10.1039/D4TB02400A ↗
24. HClO-activated fluorescence and photosensitization from an AIE nanoprobe for image-guided bacterial ablation in phagocytes10.1002/adma.202005222 ↗
25. Tumor-activated and metal–organic framework assisted self-assembly of organic photosensitizers10.1021/acsnano.0c04518 ↗
26. Universal scaffold for an activatable photosensitizer with completely inhibited photosensitivity10.1002/anie.201907510 ↗
27. Synchronized activating therapeutic nano-agent: enhancement and tracing for hypoxia-induced chemotherapy10.1016/j.biomaterials.2023.122365 ↗
28. Designing squaraine dyes with bright deep-red aggregation-induced emission for specific and ratiometric fluorescent detection of hypochlorite10.1002/adfm.202105452 ↗
29. Rationally designed heptamethine cyanine photosensitizers that amplify tumor-specific endoplasmic reticulum stress and boost antitumor immunity
30. H-aggregates of prodrug-hemicyanine conjugate for enhanced photothermal therapy and sequential hypoxia-activated chemotherapy10.1021/acsmaterialslett.2c00015 ↗
31. Hypoxia-responsive near infrared thioxanthene-hemicyanine nanoparticle for multimodal imaging-guided photothermal/photodynamic therapy10.1016/j.dyepig.2022.110583 ↗
32. NIR-II AIE liposomes for boosting type-I photodynamic and mild-temperature photothermal therapy in breast cancer treatment10.1002/adma.202411133 ↗
33. Harnessing donor cyclization strategy: converting type II to type I photosensitizers and enhancing AIE performance for NIR-II FL/MR imaging-guided photodynamic therapy under hypoxia condition
34. Multimodal phototherapy agents target lipid droplets for near-infrared imaging-guided type I photodynamic/photothermal therapy10.1016/j.actbio.2024.04.014 ↗
35. An AIE photosensitizer with simultaneous type I and type II ROS generation: efficient bacterial elimination and hypoxic tumor ablation
36. Highly efficient multifunctional organic photosensitizer with aggregation-induced emission for in vivo bioimaging and photodynamic therapy10.1021/acsami.1c17476 ↗
37. An NIR-II two-photon excitable AIE photosensitizer for precise and efficient treatment of orthotopic small-size glioblastoma
38. The midas touch by iridium: a second near-infrared aggregation-induced emission-active metallo-agent for exceptional phototheranostics of breast cancer10.1021/jacs.4c15150 ↗
39. Advanced photosensitizer activation strategies for smarter photodynamic therapy beacons10.1002/anie.201805246 ↗
40. Hierarchical nano-to-molecular disassembly of boron dipyrromethene nanoparticles for enhanced tumor penetration and activatable photodynamic therapy10.1016/j.biomaterials.2021.120945 ↗
41. Leveraging tumor microenvironment to boost synergistic photodynamic therapy, ferroptosis anti-tumor efficiency based on a functional iridium(III) complex10.1002/advs.202413879 ↗
42. Multiwfn: a multifunctional wavefunction analyzer10.1002/jcc.22885 ↗
43. Bioorthogonal activation and mitochondrial targeting of a near-infrared-emitting iridium(III) nitrone complex via cyclooctynylated phosphonium cations for enhanced cellular imaging and photodynamic therapy10.1039/D5QI01139F ↗
44. Mitochondrial electron flow dynamics imaging for assessing mitochondrial quality and drug screening
45. Photoactivated self-assembled nanomicelles integrating mitophagy inhibition to enhance pyroptosis for cancer immunotherapy
46. A small-molecule drug for the self-checking of mitophagy
47. Binary cooperative prodrug nanoparticles improve immunotherapy by synergistically modulating immune tumor microenvironment10.1002/adma.201803001 ↗
48. Polyphotosensitizer-based nanoparticles with michael addition acceptors inhibiting GST activity and cisplatin deactivation for enhanced chemotherapy and photodynamic immunotherapy
49. Immunogenic cell death and DAMPs in cancer therapy10.1038/nrc3380 ↗
50. A PTT-induced feed-back carbon nanosystem for enhanced breast cancer therapy by extracellular matrix remodeling10.1021/acs.nanolett.4c05625 ↗
51. β-ketoenamine covalent organic framework nanoplatform combined with immune checkpoint blockade via photodynamic immunotherapy inhibit glioblastoma progression
52. Chimeric peptide-engineered polyprodrug enhances cytotoxic T cell response by inducing immunogenic cell death and upregulating major histocompatibility complex class I10.1021/acsnano.4c12197 ↗